BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 15079851)

  • 1. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
    Mulas F; Roselló B; Morant A; Hernández S; Pitarch I
    Rev Neurol; 2002 Jul 1-15; 35(1):17-24. PubMed ID: 12389187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does methylphenidate influence cognitive performance?
    Solanto MV
    J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1323-5. PubMed ID: 9334541
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving decision making in the treatment of ADHD.
    Vitiello B
    Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate: its pharmacology and uses.
    Challman TD; Lipsky JJ
    Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychopharmacological effects of methylphenidate].
    Ikeda K; Takamatsu Y; Hagino Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexmethylphenidate (Focalin) for ADHD.
    Med Lett Drugs Ther; 2002 May; 44(1130):45-6. PubMed ID: 12011757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylphenidate double-blind trial: indication and performing].
    Bliznakova L; Gerstner S; Schmidt MH; Becker K
    Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 19. Central auditory processing disorder and ADHD.
    Jerome L
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):399-400. PubMed ID: 10761339
    [No Abstract]   [Full Text] [Related]  

  • 20. [Raynaud phenomenon as adverse effect of ADHD treatment].
    Lakartidningen; 2008 Dec 10-16; 105(50):3662-3. PubMed ID: 19177933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.